RCE News: Recce Pharmaceuticals Announces Change of Director’s Interest Notices – James Graham - 28th Jun 2023, 10:00pm

annb0t

Top 20
Recce Pharmaceuticals

SYDNEY, Australia, June 28, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Limited (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to provide a notice of change of interests in Director holdings.

The Company advises that Chief Executive Officer James Graham has increased his shareholding through the on-market purchase of an additional 500,000 shares totaling AUD $306,871.75.

19th June–22ndJune2023 Personwhoserelevant...

>>> Read more: Recce Pharmaceuticals Announces Change of Director’s Interest Notices – James Graham
 
Top Bottom